Shutting down the ALK-1 receptor inhibits the VEGF pathway. Response seen in patients who had used antiangiogenic therapy. VEGF therapies might work best in combination. SAN FRANCISCO — Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which...
Posted to
News
by
AACR News
on
Sun, Nov 13 2011
Filed under:
Filed under: Press Releases, Research, Treatment, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, National Cancer Institute, NCI, tumor suppressor, angiogenesis, Molecular Targets, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Cancer Therapeutics, EORTC, metastasis, European Organisation for Research and Treatment of Cancer, Dr. Filippo de Braud, antiangiogenesis, monoclonal antibody, VEGF therapy
Tweet • The tumor suppressor PTEN played key role in radiation damage repair. • Skin cancer is the most common type of cancer in the United States. PHILADELPHIA — Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation...
Posted to
News
by
AACR News
on
Tue, Jul 26 2011
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, prevention, Cancer Research, skin cancer, chemoprevention, xeroderma pigmentosum C, University of Chicago, common cancer, UVB radiation, tumor suppressor, XPC, Pten, non-melanoma skin cancer, DNA damage, Yu-Ying He